SCHEMBL22862047

SCHEMBL22862047

COc1cc(C(c2ccc(-c3ccccc3)cc2)c2ccc(NC(=O)/C=C/C(=O)O)c(OC)c2)ccc1NC(=O)/C=C/C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.61
▸ LMNA P02545 1/20 0.61
▸ GAA P10253 2/20 0.60
▸ ALDH1A1 P00352 7/20 0.55
▸ GLA P06280 1/20 0.55
▸ MAPT P10636 4/20 0.51
▸ KDM4E B2RXH2 3/20 0.51
▸ CREBBP Q92793 1/20 0.49
▸ LTB4R Q15722 2/20 0.48
▸ HTT P42858 3/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ EGFR P00533 1/20 0.46
▸ MMP1 P03956 1/20 0.46
▸ MMP2 P08253 1/20 0.46
▸ MMP9 P14780 1/20 0.46
▸ PKM P14618 1/20 0.44
▸ CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22862070 0.96 GAA (0.64) SMN1; SMN2LMNAGAAALDH1A1GLA
SCHEMBL22880083 0.96 ALDH1A1 (0.57) SMN1; SMN2LMNAGAAALDH1A1GLA
SCHEMBL22880082 0.88 SMN1; SMN2 (0.47) SMN1; SMN2LMNAGAAALDH1A1GLA
SCHEMBL22880309 0.84 GAA (0.50) SMN1; SMN2LMNAGAAALDH1A1GLA
SCHEMBL22862132 0.83 ALDH1A1 (0.62) SMN1; SMN2LMNAALDH1A1MAPTKDM4E
SCHEMBL22862090 0.83 ALDH1A1 (0.62) SMN1; SMN2LMNAALDH1A1MAPTKDM4E
SCHEMBL22862129 0.81 KDM4E (0.63) SMN1; SMN2LMNAGAAALDH1A1MAPT
SCHEMBL22862103 0.81 SMN1; SMN2 (0.60) SMN1; SMN2LMNAGAAALDH1A1GLA
SCHEMBL22862150 0.80 KDM4E (0.65) SMN1; SMN2LMNAGAAALDH1A1MAPT
SCHEMBL22862048 0.77 ALDH1A1 (0.82) SMN1; SMN2LMNAGAAALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210003921-A1 COMPOUND, RESIN, COMPOSITION, AND FILM FORMING MATERIAL FOR LITHOGRAPHY USING THE SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-01-07 — — US disclosed
EP-3760611-A1 COMPOUND, RESIN, COMPOSITION AND FILM-FORMING MATERIAL FOR LITHOGRAPHY USING SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-01-06 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210003921-A1 COMPOUND, RESIN, COMPOSITION, AND FILM FORMING MATERIAL FOR LITHOGRAPHY USING THE SAME COL1A1, MLLT3, F12 SMN1; SMN2 2172/4885LMNA 26/4885GAA 3407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback